194 results on '"Korth-Bradley, Joan M."'
Search Results
2. An Open-label, Single-dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A
3. Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B
4. Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis
5. Regulatory Framework for Drug Development in Rare Diseases
6. Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa
7. Translational Research: Preclinical to Healthy Volunteer to Patient
8. Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies
9. Lack of Effect of Rivipansel on QTc Interval in Healthy Adult African American Male Subjects
10. First open-label, single-arm, prospective study of real-world use of FIX replacement therapy in a predominantly pediatric hemophilia B population in China
11. Pancreatitis in tigecycline Phase 3 and 4 clinical studies
12. Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects
13. Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring
14. Reassessment of Tigecycline Bone Concentrations in Volunteers Undergoing Elective Orthopedic Procedures
15. The effect of rifampin on the pharmacokinetics of sirolimus in healthy volunteers
16. The comparability of etanercept pharmacokinetics in healthy Japanese and American subjects
17. Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse
18. Chiral Bioequivalence: Effect of Absorption Rate on Racemic Etodolac
19. Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function
20. Comparative Sirolimus Pharmacokinetics After Single-Dose Administration of Two Prototype 0.5-mg Tablets in Healthy Volunteers
21. Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin
22. Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
23. Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel
24. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
25. The pharmacokinetics of etanercept in patients with heart failure
26. First open-label, single-arm, prospective study of real-world use of FIX replacement therapy in a predominantly pediatric hemophilia B population in China.
27. Assessment of the possible influence of patient demographics on the pharmacokinetics of a new antibody-chemotherapeutic agent for relapsed acute myelogenous leukemia.: 157.
28. 233. Absolute bioavailability of TNF receptor fusion protein following subcutaneous injection in healthy volunteers.
29. The Influence of Bromfenac on the Pharmacokinetics and Pharmacodynamic Responses to Glyburide in Diabetic Subjects
30. Evaluation of Pharmacokinetic Interaction Between Bromfenac and Phenytoin in Healthy Males
31. Population Pharmacokinetics of Intravenous Amiodarone in Patients with Refractory Ventricular Tachycardia/Fibrillation
32. The Path to Perfect Pediatric Posology - Drug Development in Pediatrics
33. The Education of Prescribers for Safe and Effective Use of Medications
34. Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis
35. Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics
36. Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B
37. Comparative Bioavailability Study of Single-Dose Film-Coated and Sugar-Coated Ethionamide Tablets in Healthy Volunteers
38. How to Fix the Dangerous Lack of Clinical Pharmacology Education in the Medical Profession: The Generation of Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency
39. Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures
40. Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects
41. Factors that influence the bleeding phenotype in severe hemophilic patients
42. The effect of rifampin on the pharmacokinetics of sirolimus in healthy volunteers
43. A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients
44. Tigecycline Does Not Prolong Corrected QT Intervals in Healthy Subjects
45. The Effect of a High-Fat Breakfast on the Pharmacokinetics of Moxidectin in Healthy Male Subjects: A Randomized Phase I Trial
46. Excretion of Moxidectin into Breast Milk and Pharmacokinetics in Healthy Lactating Women
47. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
48. The Top 100 Drug Interactions: A Guide to Patient Management, 2010 Edition
49. Handbook of Basic Pharmacokinetics…Including Clinical Applications, 7th Edition
50. Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.